Companies /Healthcare

Clover Health Investments Corp - Class A

NASDAQ: CLOV Healthcare Plans
$4.93
▼ $0.03 (−0.67%) today
Markets open · 3:47pm ET

CLOV at a Glance

Valuation
Market cap
$2.7B
P/E ratio
496.0
Profitability
Revenue (TTM)
$2.7B
Profit margin
0.5%
EPS (TTM)
$0.01
Price
52-week range
$2 – $6
Street target
$5.60

Headquartered in Wilmington, DE Fiscal year ends December NASDAQ: CLOV cloverhealth.com

About Clover Health

Clover Health Investments, Corp. (Nasdaq: CLOV) describes itself as a physician enablement technology company focused on access to healthcare for people on Medicare, including seniors who have historically lacked affordable, high-quality care.

Its operations center on two pieces:
- **Clover Assistant:** a software platform that aggregates patient data from across the healthcare ecosystem. It supports clinical decision-making and the early identification and management of chronic diseases such as diabetes, chronic kidney disease, congestive heart failure and COPD.
- **Insurance:** the company's reporting segment, which offers PPO and HMO Medicare Advantage plans in several states. The emphasis is on its flagship wide-network, high-choice PPO, which holds about 98% of members and received a 5 Star rating for Payment Year 2028.

The Insurance segment generates nearly all revenue through premiums. Through its subsidiary Counterpart Health, Clover licenses its technology to external payors and providers under the Counterpart Assistant brand.

As of September 30, 2026, Clover served 158,907 Medicare Advantage members, up 45% year over year. Updated

Latest Activity

ELVElevance Health
52-week high
$446.42
+0.26%vs prior 52-week high · Oct 22, 2026

Elevance Health closed at a fresh one-year high of $446.42, 0.26% above its prior peak set on October 22. Competitor Clover Health slipped 0.2% on the day.

Related stockstoday

Moves: Nov 16, 2026 · Alpha Vantage daily close

2 have no US listing

HUMHumana
52-week high
$437.97
+1.03%vs prior 52-week high · Oct 12, 2026

The managed-care name is back at the top of its range.

Related stockstoday
CLOVClover Health
After-hours
$4.82
+9.05%off the open $4.42

The 9.05% run came the same day Humana, a competitor, posted Q3 2026 results. Managed care names moved together into the close.

Before the movelast 24 hours
  1. Earnings release
    Related company: HUM, competitor

    Humana Q3 2026 earnings release

Related stockstoday

Moves: Nov 6, 4:20 PM ET · Alpha Vantage quote

3 more related stocks · 4 have no US listing

Through Clover Assistant, we are committed to delivering better clinical quality and lower total cost of care. We are pleased that this continues to show up in our results, with ~98% of our members enrolled in our 5 Star rated PPO for Payment Year 2028, alongside our third consecutive year of nation-leading HEDIS performance.

Star ratings are where Medicare Advantage bonus money is won or lost, and while CVS and Aetna fight CMS in court over their downgrades, Clover's CEO says nearly all of its membership sits in a 5-Star plan for Payment Year 2028. That locks in bonus payments at a $2 billion company whose rivals are litigating to protect theirs.

CLOVClover Health
Q3 2026
EPS
$0.01
est $0.01+$0.00
Revenue
$759M
est $738M+2.8%

Clover Health is now running a real profit engine, turning a year-ago loss into GAAP net income of $6.4 million. Management raised the low end of every full-year 2026 target and says 2027 open enrollment is tracking well.

Quarterly EPS — reported vs estimate
Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model.

Toy is claiming Clover can grow membership and widen margins at the same time, a combination most Medicare Advantage insurers have abandoned as star ratings tighten and costs climb. For a $2 billion insurer, that claim on the Q3 call is the whole investment case, so the proof has to show up in next quarter's medical cost ratio.

Biggest movers · At the close
  • GPROGoPro$1.12+7.7%
  • CLOVClover Health$4.78+7.5%
  • BILLBill Holdings$48.93+7.1%
  • MRNAModerna$240.74+6.1%
  • ARGXargenx$874.58+5.9%
  • GMGeneral Motors$76.56-7.5%
  • GEGE Aerospace$299.39-3.8%
  • IRENIREN$26.68-3.8%
  • HWMHowmet Aerospace$211.94-3.7%
  • PWRQuanta Services$597.07-3.5%

General Motors shed 7.5% into the close, the worst showing across 387 priority names and nearly double the next-biggest decline. GoPro and Clover Health anchored the other end, each up more than 7.5%.

CLOVClover Health
Regular session
$4.71
-8.27%open $5.14

An 8.3% slide to $4.72 wipes out the $5 handle on a $2.1 billion insurer, and it lands a day after the stock already shed 6.9%. Back-to-back drops like this reset the base for anyone waiting to buy.

Biggest movers · On the open
  • AAOIApplied Optoelectronics$115.37+8.9%
  • CLOVClover Health$4.99+8.8%
  • COHRCoherent$324.08+7.2%
  • AMTAmerican Tower$178.57+7.1%
  • LITELumentum$1,120.85+6.9%
  • TMUST-Mobile US$156.09-8.9%
  • TAT&T$22.75-8.5%
  • VZVerizon$43.13-7.0%
  • JOBYJoby Aviation$5.46-5.1%
  • APLDApplied Digital$22.97-3.7%

All three major US wireless carriers are at the bottom of the board at the open, with T-Mobile down 8.9% and AT&T and Verizon close behind. Optical names lead the other side, Applied Optoelectronics up 8.9%.

Now director at CLOVER HEALTH INVESTMENTS, CORP. /DE

Clover Health is adding boardroom muscle just as CMS and insurers fight over 2027 Medicare Advantage rates, the single variable that decides whether this $1.9 billion insurtech keeps scaling. Board additions at a company this size shift who sets the growth-versus-margin call.

CLOV Coverage

7:30am ET
Investing

Is Clover Health Finally Turning the Corner?

After years of burning cash and testing investor patience, Clover Health just posted results that bulls have been waiting for. But with medical costs creeping up and the stock already priced for…

Trey Thoelcke
6:08am ET
Investing

OSCR vs. CLOV: Which Stock Is A Better Buy Now?

In this piece, we’ll check in on two mid-cap health insurance plays that are leveraging their tech-savvy and digital strengths to grab a bigger slice of the health insurance industry. Indeed, if…

Joey Frenette
1:16pm ET
Investing

Chamath Palihapitiya Loves This Stock, But Is It a Buy?

Chamath Palihapitiya is a prominent venture capitalist, engineer, and entrepreneur known for his significant contributions to the tech sector. Venture capitalists were certainly among the top influencers of the post-pandemic era, when…

Chris MacDonald

Frequently Asked Questions

What does Clover Health do?

Clover Health Investments, Corp. (Nasdaq: CLOV) describes itself as a physician enablement technology company focused on access to healthcare for people on Medicare, including seniors who have historically lacked affordable, high-quality care.

What is the CLOV stock price target?

The Wall Street consensus 12-month price target for CLOV is $5.60.